Esophagectomy Clinical Trial
Official title:
A Phase III Randomized Trial of Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy
Verified date | February 2024 |
Source | University of Pittsburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This research study is a phase III randomized trial to study the value of the addition of a pyloroplasty procedure versus no pyloroplasty procedure during the performance of esophagectomy. Pyloroplasty is a type of pyloric drainage procedure.
Status | Active, not recruiting |
Enrollment | 140 |
Est. completion date | January 2025 |
Est. primary completion date | February 14, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - Subjects must be willing to undergo esophagectomy for benign or malignant condition - Women and men 18-85 years of age - Eastern Cooperative Oncology Group (ECOG) performance status 0-2 - Stomach is used as conduit Exclusion Criteria: - Previous operations of the pylorus - Previous gastric resection - Previous gastric bypass - Patients who are unable to tolerate surgery - Participants may be enrolled and randomized on the study but may be excluded at the time of the surgery because of findings by the surgeon that preclude performing esophagectomy, or using stomach as a conduit or findings which preclude following the randomized arm. - Age <18 years of age or > 85 years of age - BMI > 50 - Liver cirrhosis or liver failure at physician's discretion |
Country | Name | City | State |
---|---|---|---|
United States | Department of Cardiothoracic Surgery | Pittsburgh | Pennsylvania |
United States | University of Pittsburgh Medical Center Presbyterian-Shadyside Hospital | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | pneumonia | Defined as meeting 3 of 5 characteristics: fever, leukocytosis, chest x-ray (CXR) with infiltrate, positive culture from sputum, or treatment with antibiotics | 30 days postoperatively | |
Primary | esophageal anastomosis leak requiring surgery | Defined as a leak at the esophageal anastomosis site as evidenced by Barium Swallow Study. | 30 days postoperatively | |
Secondary | Mortality | Death within 30 days of surgery | 30 days | |
Secondary | Time to start oral diet | Number of days from surgery to starting oral diet | Up to 24 months | |
Secondary | Quality of life assessment by completion of SF36 Quality of Life questionnaire | SF36 Quality of Life questionnaire | Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery | |
Secondary | Gastroesophageal Reflux Disease (GERD)-Health Related Quality of Life (HRQL) measured by completion of GERD HRQL questionnaire | Gastroesophageal Reflux Disease (GERD)-Health Related Quality of Life (HRQL) questionnaire prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery. | Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery. | |
Secondary | Dysphagia as reported by patient using the Dysphagia scale | Dysphagia scale measures swallowing difficulty on a scale of 1-5. (1=no difficulty swallowing; 2=difficulty swallowing hard solids; 3=difficulty swallowing soft solids; 4=difficulty swallowing liquids; 5=unable to swallow anything. A lower score represents a better outcome. | Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery. | |
Secondary | Nasogastric tube drainage measured in milliliters | Measured in milliliters | From date of surgery until date nasogastric tube is removed or date of discharge from hospital, whichever came first, assessed up to 24 months. | |
Secondary | Replacement of nasogastric tube reported as number of days from tube removal to reinsertion | Number of days from nasogastric tube removal to reinsertion | Up to 24 months | |
Secondary | Esophageal dilations reported as the number of esophageal dilations performed | Number of esophageal dilations performed | Up to 24 months | |
Secondary | Length of hospital stay | Number of days in hospital | From date of surgery until the date of discharge from hospital, assessed up to 24 months. | |
Secondary | Aspiration as reported on radiographic imaging | Radiographic imaging reports | Performed when clinically indicated up to 24 months postoperatively | |
Secondary | Gastric outlet obstruction as reported on barium swallow reports | Barium swallow reports | Performed when clinically indicated up to 24 months postoperatively | |
Secondary | Re-admission to hospital | Number of days from hospital discharge to re-admission | Up to 24 months postoperatively | |
Secondary | Unexpected return to the Operating Room | Procedure performed in the Operating Room | Up to 24 months postoperatively | |
Secondary | Esophageal anastomotic leak not requiring surgery | Barium swallow reports | Performed when clinically indicated up to 24 months postoperatively | |
Secondary | Respiratory complications other than pneumonia | Radiographic imaging reports | Performed when clinically indicated up to 24 months postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00827931 -
Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery
|
Phase 4 | |
Completed |
NCT00420017 -
Prevention of Atrial Fibrillation Following Esophagectomy
|
Phase 4 | |
Recruiting |
NCT04750096 -
Esophagectomy Enhanced Recovery After Surgery Protocol
|
||
Not yet recruiting |
NCT06147180 -
Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
|
||
Recruiting |
NCT03835273 -
Oesophagectomy and Chest Wall and Respiratory Function
|
||
Enrolling by invitation |
NCT02086461 -
Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay
|
N/A | |
Recruiting |
NCT00260559 -
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
|
||
Recruiting |
NCT02017002 -
Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer
|
N/A | |
Recruiting |
NCT04654975 -
Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
|
||
Recruiting |
NCT04008420 -
The Association of Intraoperative Oxygen Reserve Index and Postoperative Pulmonary Complications in Robot-assisted Esophagectomy
|
||
Recruiting |
NCT01144325 -
Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position
|
Phase 2 | |
Completed |
NCT01169051 -
A Retrospective Analysis of Statin Use and Outcome After Thoracic Cancer Surgery
|
N/A | |
Recruiting |
NCT05950438 -
Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
|
||
Not yet recruiting |
NCT06271707 -
Stellate Ganglion Block
|
Phase 4 | |
Recruiting |
NCT02418052 -
Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE
|
N/A | |
Completed |
NCT02158286 -
Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet
|
N/A | |
Recruiting |
NCT02309619 -
Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE
|
N/A | |
Completed |
NCT05604950 -
Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
|
||
Completed |
NCT00708513 -
Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
|
N/A | |
Recruiting |
NCT02530983 -
Mayo Clinic Upper Digestive Disease Survey
|